Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Stock Information for Sanara MedTech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sanara MedTech Inc.

Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic(TM)
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.